TwelveStone Health Partners, Inc.

TwelveStone Health Partners, headquartered in Murfreesboro, US, specializes in providing Specialty Home Infusion services to patients with complex health conditions, enhancing their care experience in familiar environments. TwelveStone Health Partners, Inc. was founded in 2015 and operates primarily in the healthcare sector, focusing on Specialty Home Infusion services. The company has successfully completed four funding deals, with the most recent occurring on July 12, 2022, raising USD 12.

00 mn from Siena Healthcare Finance. Shane Reeves serves as CEO, overseeing the company’s operations and strategic direction. TwelveStone Health Partners specializes in providing Specialty Home Infusion services, which focus on delivering expert, individualized care to patients with complex and chronic health conditions. Their core offerings include administering intravenous medications, fluids, and therapies through a network of experienced registered nurses who are equipped to handle various infusion protocols.

The services aim to enhance patient comfort by allowing treatments to occur in the familiar settings of patients' homes, thereby potentially reducing hospital visits and improving overall health outcomes. TwelveStone primarily serves patients across multiple geographical markets, including Tennessee, Georgia, Kentucky, and Virginia, catering to a diverse client base that encompasses individual patients requiring home infusion therapy, healthcare providers, and medical facilities seeking outpatient infusion services. TwelveStone Health Partners operates on a transactional structure that involves direct-to-consumer interactions and partnerships with healthcare institutions. Revenue generation occurs through the provision of specialized infusion services, where patients receive personalized treatment plans tailored to their specific health needs.

The company collaborates with insurance providers to streamline payment processes, ensuring that patients incur minimal out-of-pocket costs. This model is designed to maximize accessibility and convenience for clients while maintaining a high standard of care. Additionally, potential revenue streams may include contracts with hospitals and clinics for outpatient infusion services, enhancing the company’s footprint in the healthcare market and facilitating smoother care transitions for patients. In July 2022, TwelveStone Health Partners, Inc.

raised USD 12. 00 mn in venture funding, led by Heritage Group, which will be utilized to support the company’s expansion plans in the southeastern United States. The firm aims to extend its services into new geographic regions, enhancing its market presence and access to patients needing specialized home infusion therapy.